Article
In silico and in vitro analysis of recombinant arginine deiminase from Pseudomonas furukawaii as a potential anticancer enzyme
2022-01-21
Abstract excerpt
<title>Abstract</title> <p>Arginine deiminase (ADI), a promising anticancer enzyme from <italic>Mycoplasma hominis, </italic>is currently in phase III of clinical trials for the treatment of arginine auxotrophic tumors. However, it has been associated with several drawbacks in terms of low stability at human physiological conditions, high immunogenicity, hypersensitivity and systemic toxicity. In our previous wor...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 90eef57c-b4fe-5637-b4a4-44f904bbdbfb
- DOI
- 10.21203/rs.3.rs-1000203/v3
